PMET Announces Up To Aggregate C$130 Million Financings to Advance Shaakichiuwaanaan - Through a Flow-Through Private Placement and a Public Offering of Common Shares
/NOT FOR RELEASE TO U.S. NEWS WIRE SERVICES OR DISTRIBUTION IN THE UNITED STATES/ Proceeds to support updated CV5 Feasibility Study, advancement of critical minerals co-products and unlocking value through exploration success The prospectus...
ASUS Announces ROG Strix Aiolos
20Gbps USB 3.2 Gen 2x2 SSD enclosure with heat-resistant liquid-silicone coating and real-time ROG SSD dashboard KEY POINTS Blazing-fast: USB-C® 3.2 Gen 2x2 for up to 20Gbps transfer speeds via a versatile dual M.2 interface Strength and style:...
Penfolds Announces Partnership with the FORMULA 1 QATAR AIRWAYS AUSTRALIAN GRAND PRIX 2026
The partnership arrives as Penfolds marks 75 years of Grange MELBOURNE, Feb. 9, 2026 /PRNewswire/ -- Today, Penfolds announced its partnership with the FORMULA 1 QATAR AIRWAYS AUSTRALIAN GRAND PRIX 2026, joining the iconic global spectacle as an...
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
BEIJING, Feb. 6, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new...
Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia
SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received...
Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer
CHENGDU, China, Feb. 6, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-directed ADC sacituzumab tirumotecan (sac-TMT, also...
BIEL Announces Establishment of BIEL Charity Trust
HONG KONG, Feb. 6, 2026 /PRNewswire/ -- The BIEL Crystal Charity Trust has been officially established, marking a strategic upgrade in the company's philanthropic initiatives. By adopting a standardized, professional charitable trust framework, this...
Everest Medicines Announces China NMPA Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis
SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...
Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors
Leah Goodman brings a wealth of policy and regulatory experience and is a recognized leader in Australia for advancing scientific discoveries to patient impacts. CALGARY, AB and BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ -- Providence...
Dingdong Announces Entry into Definitive Agreement to Sell its China Business to Meituan
SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, today announced that it has entered into a definitive Share Purchase Agreement (the...